Introduction: The ACE I/D polymorphism was mostly investigated in association with intima-media thickness, rarely with severe atherosclerotic phenotype.
Materials and methods: We investigated the association of I/D polymorphism with severe carotid atherosclerosis (CA) (stenosis > 70%) in asymptomatic and symptomatic patients undergoing carotid endarterectomy. The 504 patients subjected to endarterectomy and 492 healthy controls from a population in Serbia were investigated as a case-control study.
Results: The univariate logistic regression analysis revealed ACE DD as a significant risk factor for severe CA (odds ratio [OR] = 1.3, 95% confidence interval [CI] 1.0–1.7, p = 0.04). After adjustment for the common risk factors (age, hypertension, smoking, and HDL) ACE was no longer significant. However, we found a significant independent influence of DD genotype on plaque presence in a normotensive subgroup of patients (OR 1.8, CI 1.2–3.0, p = 0.01, corrected for multiple testing). In symptomatic patients D allele carriers were significantly more frequent compared with asymptomatic patients (OR 1.6 CI 1.0–2.6, p = 0.05).
Conclusions: Our data suggests that ACE I/D is not an independent risk factor for severe CA. On the other hand, a significant independent genetic influence of ACE I/D appeared in normotensive and symptomatic patients with severe CA. This should be considered in further research toward resolving the complex genetic background of severe CA phenotype.
FukuharaMGearyRLDizDI. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension2000; 35: 353–359.
4.
KuniedaTMinaminoTNishiJ. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation2006; 114: 953–960.
5.
BrasierARRecinosA3rdEledrisiMS. Vascular inflammation and the renin–angiotensin system. Arterioscler Thromb Vasc Biol2002; 22: 1257–1266.
6.
HeenemanSSluimerJCDaemenMJ. Angiotensin-converting enzyme and vascular remodeling. Circ Res2007; 101: 441–454.
7.
DietFPrattREBerryGJMomoseNGibbonsGHDzauVJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation1996; 94: 2756–2767.
Jandeleit-DahmKJacksonBPaxtonDPerichRJohnstonCI. Characterisation of angiotensin converting enzyme from different rat vascular beds. Blood Press1995; 4: 170–176.
10.
ShenXZLukacherAEBilletSWilliamsIRBernsteinKE. Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors. J Biol Chem2008; 283: 9957–9965.
11.
RigatBHubertCAlhenc-GelasF. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990; 86: 1343–1346.
12.
SuehiroTMoritaTInoueM. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet2004; 115: 91–96.
13.
SchmiederREHilgersKFSchlaichMPSchmidtBM. Renin–angiotensin system and cardiovascular risk. Lancet2007; 369: 1208–1219.
SamaniNJThompsonJRO’TooleLChannerKWoodsKL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation1996; 94: 708–712.
16.
Agerholm-LarsenBNordestgaardBGTybjaerg-HansenA. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol2000; 20: 484–492.
17.
StankovićAZivkovićMAlavantićD. Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Clin Lab Invest2002; 62: 469–475.
18.
Sayed-TabatabaeiFAHouwing-DuistermaatJJvan DuijnCMWittemanJC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke2003; 34: 1634–1639.
19.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med1991; 325: 445–453.
20.
European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) stenosis. Lancet1991; 337: 1235–1243.
21.
RothwellPMGibsonRJSlatteryJSellarRJWarlowCP, for the European Carotid Surgery Trialists’ Collaborative Group. Equivalence of measurements of carotid stenosis: a comparison of three methods on 1001 angiograms. Stroke1994; 25: 2435–2439.
22.
FriedwaldWTLevyRIFredricksonDS. Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem1972; 18: 499–502.
23.
KunkelLMSmithKDBoyerSH. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA1977; 74: 1245–1249.
24.
StankovićAIlićNŽunićZGlišićSAlavantićD. Association of the insertion/deletion polymorphism at the angiotensin I-converting enzyme locus with arterial blood pressure: population-based study. Yugoslav Med Biochem1999; 18: 141–147.
25.
HungJMcQuillanBMNidorfMThompsonPLBeilbyJP. Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population. Arterioscler Thromb Vasc Biol1999; 19: 1969–1974.
26.
MannamiTKatsuyaTBabaS. Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study. Stroke2001; 32: 1250–1256.
27.
Sayed-TabatabaeiFASchutAFHofmanA. A study of gene–environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet2004; 41: 99–103.
28.
WatanabeYIshigamiTKawanoY. Angiotensin-converting enzyme gene I/D polymorphism and carotid plaques in Japanese. Hypertension1997; 30: 569–573.
29.
KostulasKHuangWXCrisbyM. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest1999; 29: 478–483.
30.
Dessi-FulgheriPCataliniRSarzaniR. Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens1995; 13: 1593–1596.
31.
NiemiecPZakIWitaK. The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. Clin Chem Lab Med2008; 46: 446–452.
32.
TsezouAKarayannisGGiannatouEPapanikolaouVTriposkiadisF. Association of renin–angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst2008; 9: 202–207.
33.
SuTCChienKLJengJS. Pulse pressure, aortic regurgitation and carotid atherosclerosis: a comparison between hypertensives and normotensives. Int J Clin Pract2006; 60: 134–140.
34.
EvansAEPoirierOKeeF. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med1994; 87: 211–214.
35.
De DenusS. Pharmacogenomic testing for angiotensin-converting enzyme inhibitors: getting ready for prime time. Pharmacogenomics2010; 11: 1345–1348.
